In accordance with the ‘Order for Change in Drug Approval Matters’ (Drug Review and Coordination Department-No. 4920, effective date August 20, 2015), the precautions for use of Bonvironju have been changed.


For further details, please refer to the ‘Product Introduction’ section and attached documents.